Moreover, similar to CASP8, more than 40% of GBM cell lines display significant methylation in TRAIL-R1 gene promoter [63], possibly revealing an extensive epigenetic regulation in TRAIL resistance in GBM. The gene discussed is CASP8; the disease is glioblastoma.